You are here: Industry Insights > virus

News List

Sesderma communicates the effectiveness of Lactyferrin Forte Solution for COVID-19 expresspharma
April 30, 2020
Lactyferrin (LF) is known to exhibit medicinal properties and strengthen the immune system.
Key nose cells identified as likely COVID-19 virus entry points worldpharmanews
April 26, 2020
Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to g
PDI’s Infection Prevention Products to be tested Against SARS-CoV-2 americanpharmaceuticalreview
April 21, 2020
PDI Healthcare is testing several of its disinfectant products for efficacy against SARS-CoV-2, the virus that causes COVID-19, for submission to the EPA for approval.
No traces of COVID-19 virus found in the imported raw material: Jubilant Life Sciences expresspharma
April 20, 2020
None of the employees tested positive so far travelled overseas in the last six month, the company announced in a press release.
BMGF Expands COVID-19 Commitment to more than $250 million expresspharma
April 17, 2020
New funding will help life sciences companies secure financing to develop diagnostics, therapeutics, and vaccines for COVID-19.
A dive into COVID-19 treatment avenues expresspharma
April 16, 2020
“Frost & Sullivan’s analysis reveals that hydroxychloroquine and Remdesivir are likely to emerge as important treatment strategies for COVID-19,” ...
AIkido Pharma Inks Exclusive License for Antiviral Drug Platform contractpharma
April 15, 2020
Pan-viral inhibitory compound with efficacy against multiple viral pathogens including Influenza, SARS-COV, MERS-COV, Ebola and Marburg virus.
Lancaster academic sees positives in first published clinical trial of COVID-19 treatment worldpharmanews
April 07, 2020
A Lancaster University statistician who worked on the first published large randomised clinical trial for a potential treatment for the COVID-19 virus said the scientific community was coming together to combat the coronavirus.
Possible coronavirus drug identified by Australian scientists worldpharmanews
April 06, 2020
A collaborative study led by Monash University's Biomedicine Discovery Institute (BDI) in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity (Doherty Institute).
Amgen and Adaptive Biotechnologies to develop Covid-19 drug pharmaceutical-technology
April 06, 2020
Amgen has partnered with Adaptive Biotechnologies to develop a drug candidate that could prevent and treat Covid-19 coronavirus infection.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page